Literature DB >> 11429424

Microsatellite instability in inflamed and neoplastic epithelium in ulcerative colitis.

T Ishitsuka1, H Kashiwagi, F Konishi.   

Abstract

BACKGROUND: Several genetic alterations have been documented in dysplasia and cancer developing in ulcerative colitis (UC). However, the microsatellite instability (MSI) status has rarely been described, especially in the inflamed epithelium of UC. AIMS: To study MSI status during neoplastic and inflammatory changes in UC.
METHODS: Seventy five surgically resected samples of colorectal mucosa, taken from 16 colectomy specimens of patients with UC were examined: five patients had a long duration with dysplasia or cancer (UC-LD with neoplasm), seven patients had a long duration without neoplastic changes (UC-LD without neoplasm), and four patients had a short duration without neoplastic changes (UC-SD). In addition to MSI status examined by six microsatellite markers, p53 expression was compared among the three groups.
RESULTS: With regard to non-neoplastic inflamed epithelium, MSI in two or more loci (MSI> or =2) was seen more frequently in the UC-LD without neoplasm group than in the UC-SD group (six of 14 v one of 12; p = 0.060), and significantly more often than in the UC-LD with neoplasm group (six of 14 v two of 23; p = 0.016). In the UC-LD without neoplasm group, MSI> or =2 was detected significantly more frequently in patients with severe inflammation than in those with mild inflammation (six of nine v none of five; p = 0.028). With regard to neoplastic epithelium in the UC-LD with neoplasm group, MSI in two or more loci was found in three of 17, and p53 overexpression was seen in 11 of 17 of the neoplastic lesions.
CONCLUSIONS: A high incidence of MSI in long standing UC with severe inflammation probably reflects genomic instability caused by repeated inflammatory stress. Thus, the influence of inflammation should be considered when estimating MSI in UC. It is possible that changes in p53 expression are important in the development of cancer in UC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11429424      PMCID: PMC1731482          DOI: 10.1136/jcp.54.7.526

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  The value of rectal biopsy in the diagnosis of ulcerative colitis.

Authors:  S G MATTS
Journal:  Q J Med       Date:  1961-10

2.  Altered microsatellites in incomplete-type intestinal metaplasia adjacent to primary gastric cancers.

Authors:  T Hamamoto; H Yokozaki; S Semba; W Yasui; S Yunotani; K Miyazaki; E Tahara
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

3.  Cancer risk and life expectancy of children with ulcerative colitis.

Authors:  G J Devroede; W F Taylor; W G Sauer; R J Jackman; G B Stickler
Journal:  N Engl J Med       Date:  1971-07-01       Impact factor: 91.245

4.  Regenerative lesions in ulcerative colitis are characterized by microsatellite mutation.

Authors:  C D Heinen; A E Noffsinger; J Belli; J Straughen; J Fischer; J Groden; C M Fenoglio-Preiser
Journal:  Genes Chromosomes Cancer       Date:  1997-07       Impact factor: 5.006

Review 5.  The precarcinomatous phase of ulcerative colitis.

Authors:  R H Riddell
Journal:  Curr Top Pathol       Date:  1976

6.  BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines.

Authors:  J M Hoang; P H Cottu; B Thuille; R J Salmon; G Thomas; R Hamelin
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

7.  A transforming growth factor beta 1 receptor type II mutation in ulcerative colitis-associated neoplasms.

Authors:  R F Souza; J Lei; J Yin; R Appel; T T Zou; X Zhou; S Wang; M G Rhyu; K Cymes; O Chan; W S Park; M J Krasna; B D Greenwald; J Cottrell; J M Abraham; L Simms; B Leggett; J Young; N Harpaz; S J Meltzer
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

8.  Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation.

Authors:  M L Cravo; C M Albuquerque; L Salazar de Sousa; L M Glória; P Chaves; A Dias Pereira; C Nobre Leitão; M G Quina; F Costa Mira
Journal:  Am J Gastroenterol       Date:  1998-11       Impact factor: 10.864

9.  Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis.

Authors:  T A Brentnall; D A Crispin; M P Bronner; S P Cherian; M Hueffed; P S Rabinovitch; C E Rubin; R C Haggitt; C R Boland
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

10.  Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue.

Authors:  H Peng; G Chen; M Du; N Singh; P G Isaacson; L Pan
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

View more
  14 in total

1.  Loss of fragile histidine triad protein expression in inflammatory bowel disease.

Authors:  Chun-Mei Xu; Chuan-Hu Qiao
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

2.  Role for epithelial dysregulation in early-onset colitis-associated colon cancer in Gi2-alpha-/- mice.

Authors:  Robert A Edwards; Kehui Wang; Jennifer S Davis; Lutz Birnbaumer
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

Review 3.  Cancer in inflammatory bowel disease: lessons from animal models.

Authors:  Daniel A Sussman; Rebeca Santaolalla; Sebastian Strobel; Rishu Dheer; Maria T Abreu
Journal:  Curr Opin Gastroenterol       Date:  2012-07       Impact factor: 3.287

4.  Reactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.

Authors:  Florian Kuehn; Ernst Klar; Anja Bliemeister; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

5.  Marine ω-3 polyunsaturated fatty acids and risk of colorectal cancer according to microsatellite instability.

Authors:  Mingyang Song; Reiko Nishihara; Kana Wu; Zhi Rong Qian; Sun A Kim; Yasutaka Sukawa; Kosuke Mima; Kentaro Inamura; Atsuhiro Masuda; Juhong Yang; Charles S Fuchs; Edward L Giovannucci; Shuji Ogino; Andrew T Chan
Journal:  J Natl Cancer Inst       Date:  2015-03-25       Impact factor: 13.506

6.  Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.

Authors:  Noriyoshi Fukushima; Norihiro Sato; Takashi Ueki; Christophe Rosty; Kimberly M Walter; Robb E Wilentz; Charles J Yeo; Ralph H Hruban; Michael Goggins
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

7.  Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.

Authors:  N Jewel Samadder; Bhramar Mukherjee; Shu-Chen Huang; Jaeil Ahn; Hedy S Rennert; Joel K Greenson; Gad Rennert; Stephen B Gruber
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

8.  The promoter methylation status of the DNA repair gene O6-methylguanine-DNA methyltransferase in ulcerative colitis.

Authors:  Shunji Matsumura; Naohide Oue; Reiko Ito; Hirofumi Nakayama; Yasuhiko Kitadai; Hiroshi Yokozaki; Kazuaki Chayama; Wataru Yasui
Journal:  Virchows Arch       Date:  2003-08-15       Impact factor: 4.064

Review 9.  Inflammatory colonic carcinogenesis: a review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis.

Authors:  Marco Scarpa; Ignazio Castagliuolo; Carlo Castoro; Anna Pozza; Melania Scarpa; Andromachi Kotsafti; Imerio Angriman
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

10.  Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer.

Authors:  Hamed Khalili; Jian Gong; Hermann Brenner; Thomas R Austin; Carolyn M Hutter; Yoshifumi Baba; John A Baron; Sonja I Berndt; Stéphane Bézieau; Bette Caan; Peter T Campbell; Jenny Chang-Claude; Stephen J Chanock; Constance Chen; Li Hsu; Shuo Jiao; David V Conti; David Duggan; Charles S Fuchs; Manish Gala; Steven Gallinger; Robert W Haile; Tabitha A Harrison; Richard Hayes; Aditi Hazra; Brian Henderson; Chris Haiman; Michael Hoffmeister; John L Hopper; Mark A Jenkins; Laurence N Kolonel; Sébastien Küry; Andrea LaCroix; Loic Le Marchand; Mathieu Lemire; Noralane M Lindor; Jing Ma; JoAnn E Manson; Teppei Morikawa; Hongmei Nan; Kimmie Ng; Polly A Newcomb; Reiko Nishihara; John D Potter; Conghui Qu; Robert E Schoen; Fredrick R Schumacher; Daniela Seminara; Darin Taverna; Stephen Thibodeau; Jean Wactawski-Wende; Emily White; Kana Wu; Brent W Zanke; Graham Casey; Thomas J Hudson; Peter Kraft; Ulrike Peters; Martha L Slattery; Shuji Ogino; Andrew T Chan
Journal:  Carcinogenesis       Date:  2015-06-12       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.